ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Physician Assistant

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,997Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 154

$681K Total Retail Price of All Prescriptions

Rank: 1 out of 154

473 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
64% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in West Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 473 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Risky Drugs to Seniors

1% of this provider’s 7,327 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $66 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 9.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in West Virginia
LISINOPRIL 497 324 1 1
LEVOTHYROXINE SODIUM 426 304 2 2
METFORMIN HCL 411 253 3 5
FUROSEMIDE 376 287 4 6
SIMVASTATIN 339 248 5 3
GLIMEPIRIDE 297 192 6 35
OMEPRAZOLE 286 166 7 4
GABAPENTIN 268 200 8 11
NEXIUM 226 104 9 12
SERTRALINE HCL 219 144 10 15
METOPROLOL TARTRATE 194 164 11 9
AMLODIPINE BESYLATE 191 135 12 7
LOSARTAN POTASSIUM 184 140 13 27
METOPROLOL SUCCINATE 173 136 14 10
RANITIDINE HCL 163 125 15 21
HYDROCHLOROTHIAZIDE 159 99 16 8
ATORVASTATIN CALCIUM 148 96 17 17
DONEPEZIL HCL 145 142 18 92
PRAVASTATIN SODIUM 142 86 19 16
PROAIR HFA 140 71 20 28
CRESTOR 134 87 21 14
POTASSIUM CHLORIDE 120 108 22 24
JANUVIA 113 81 23 87
CITALOPRAM HBR 105 52 24 18
NAMENDA 102 100 25 121
ATENOLOL 101 64 26 19
CLOPIDOGREL 91 70 27 22
MELOXICAM 88 32 28 41
LANTUS SOLOSTAR 87 50 29 93
LANTUS 79 58 30 83
COMBIVENT 78 52 31 97
FLUCONAZOLE 77 43 32 132
CYCLOBENZAPRINE HCL 77 13 R 32 90
DIOVAN 75 75 34 58
LISINOPRIL-HYDROCHLOROTHIAZIDE 74 46 35 53
ADVAIR DISKUS 74 47 35 61
FENOFIBRATE 73 47 37 71
CLONIDINE HCL 70 37 38 91
PREDNISONE 63 52 39 49
TRAMADOL HCL 61 42 40 13
ZETIA 60 52 41 77
DIGOXIN 59 52 42 79
PEN NEEDLE 59 36 42 111
ESCITALOPRAM OXALATE 58 53 44 46
NATEGLINIDE 57 53 45 148
FLUTICASONE PROPIONATE 57 41 45 34
CYMBALTA 56 22 47 25
ACTOS 56 46 47 151
AMITRIPTYLINE HCL 56 35 R 47 84
TRICOR 54 27 50 112
TRIAMCINOLONE ACETONIDE 53 39 51 47
PLAVIX 53 40 51 43
LEVOFLOXACIN 52 28 53 88
SPIRIVA 51 35 54 42
ISOSORBIDE MONONITRATE ER 51 42 54 63
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 18, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.